Recruiting Scleroderma Studies in Los Angeles
About Scleroderma Clinical Trials in Los Angeles
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 6 scleroderma clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 1,102 participants. Research is being sponsored by Scleroderma Research Foundation, Inc., GlaxoSmithKline, Novartis Pharmaceuticals and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in Los Angeles — FAQ
Are there scleroderma clinical trials in Los Angeles?
Yes, there are 6 scleroderma clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 6 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated July 17, 2026 from ClinicalTrials.gov